MedPath
HSA Approval

TEMGESIC INJECTION 0.3 mg/ml

SIN06116P

TEMGESIC INJECTION 0.3 mg/ml

TEMGESIC INJECTION 0.3 mg/ml

May 17, 1991

ZUELLIG PHARMA PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZUELLIG PHARMA PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS, INTRAMUSCULAR

Medical Information

N02AE01

buprenorphine

Manufacturer Information

ZUELLIG PHARMA PTE. LTD.

RECKITT BENCKISER HEALTHCARE (UK) LTD

Active Ingredients

BUPRENORPHINE HCl EQV BUPRENORPHINE

0.3 mg/ml

Buprenorphine

Documents

Package Inserts

Temgesic Injection PI.pdf

Approved: January 21, 2016

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TEMGESIC INJECTION 0.3 mg/ml - HSA Approval | MedPath